|
Route of administration |
Oral |
Formulation 1 |
Formulation 2 |
Intravenous |
Dose (mg/kg) |
50 |
50 |
10 |
AUC(0-t)(µg.hr/mL) |
5.87 ± 0.24 |
11.61 ± 0.28 |
7.50 ± 0.94 |
Cmax/C0(µg/mL) |
1.31 ± 0.06 |
1.0 ± 0.12 |
5.29 ± 1.41 |
Tmax(hr) |
3.00 |
2.00 |
- |
Kel (1/hr) |
- |
- |
0.62 ± 0.10 |
t1/2( hr) |
- |
- |
1.14 ± 0.20 |
Vd(lit) |
- |
- |
1.99 ± 0.49 |
Cl(ml/kg/min) |
- |
- |
22.48 ± 0.16 |
bioavailability (%) |
16.7 |
33.02 |
|
t is 5 and 24 h for iv and oral, respectively |